Episode 15: Cancer Immunotherapy Trends to Impact Patients and R&D
- Author
- Cambridge Healthtech Institute
- Published
- Wed 18 Mar 2020
- Episode Link
- None
Today’s episode features a conversation with Dr. Tatiana Novobrantseva, Co-Founder and CSO of Verseau Therapeutics. In this interview, we discuss five trends in the development of cancer immunotherapies and how these will impact patients and biopharmaceutical research and development.
